Clinical trial condition

AML

Explore clinical trials studying AML. Study availability and eligibility vary by location and protocol.

139 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

AML trial results

Active, not recruiting

A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AML

NCT05199051

Conditions: AML, Disease Attributes, Hematologic Diseases, +10 more
Locations: CHU d'Amiens Amiens, France

CHU d'Angers Angers, France

CHU Bordeaux Bordeaux, France

CHU de Caen Caen, France

View Trial Details

Active, not recruiting

Incidence and Risk Factors for the Development of Invasive Fungal Infection in Patients Diagnosed With Acute Myeloblastic Leukemia (HIFA)

NCT07060612

Conditions: AML
Locations: Hospital Universitario y Politécnico La Fe Valencia, Spain

View Trial Details

Active, not recruiting

Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML

NCT03021330

Conditions: AML
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Active, not recruiting

Efficacy and Safety of Chidamide in CBF Leukemia

NCT03031262

Conditions: AML
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Active, not recruiting

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

NCT04730258

Conditions: AML, Acute Myeloid Leukemia, Bone Marrow Diseases, +19 more
Locations: City of Hope Duarte, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

Norton Cancer Institute - Saint Matthews Louisville, Kentucky, United States

New York Presbyterian Weill Cornell Medical Center New York, United States

View Trial Details

Active, not recruiting

Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia

NCT02665065

Conditions: AML, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, +12 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Yale Cancer Center New Haven, Connecticut, United States

Georgetown University Medical Center Washington D.C., District of Columbia, United States

Mayo Clinic Jacksonville, Florida, United States

View all 24 locations

View Trial Details

Completed

Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure

NCT01188174

Conditions: AML
Locations: CHU de Bordeaux Bordeaux, France

CHU Caen Caen, France

CHRU lille Lille, France

Hôpital Edouard Herriot Lyon, France

View Trial Details

Completed

Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)

NCT00863148

Conditions: ALL, AML, BAL, +1 more
Locations: Hôpital Edouard Herriot Lyon, France

Institut Paoli Calmettes Marseille, France

Nantes University hospital Nantes, France

Hôpital Saint Louis Paris, France

View Trial Details

Completed

Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML

NCT04061239

Conditions: AML, MDS
Locations: Ordensklinikum Linz Elisabethinen GmbH Linz, Austria

Universitätsklinikum Aachen Aachen, Germany

Universitätsklinikum Augsburg Augsburg, Germany

Charité - Universitätsmedizin Berlin Berlin, Germany

View all 27 locations

View Trial Details

Completed

Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission

NCT01096602

Conditions: AML, Acute Myelogenous Leukemia, Hematologic Diseases, +6 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

AML

AML trial results

Related conditions